dehydrogenas
enzym
present
cytoplasm
human
cell
particip
pentos
phosphat
pathway
suppli
reduc
energi
maintain
level
coenzym
nicotinamid
adenin
dinucleotid
phosphat
nadph
defici
xlink
inherit
gene
consist
exon
approxim
situat
distal
long
arm
x
chromosom
mutat
gene
report
result
protein
variant
differ
level
enzym
activ
nadph
essenti
oxid
antioxid
system
cell
antioxid
pathway
nadph
maintain
reduc
form
glutathion
protect
cell
oxid
damag
reduct
cell
caus
accumul
redox
oxid
speci
ro
lead
senesc
haemolysi
red
blood
cell
hand
nadph
also
involv
oxid
pathway
produc
ro
although
overproduct
ro
may
advers
affect
cell
function
cell
immun
system
also
need
reactiv
speci
kill
invad
organ
phagocyt
immun
system
need
reactiv
speci
kill
invad
pathogen
part
innat
immun
system
case
sever
defici
lack
oxid
metabol
caus
reduct
oxygendepend
phagocytosi
observ
chronic
granulomat
diseas
allow
viral
replic
dehydrogenas
defici
affect
million
peopl
world
preval
approxim
africa
rang
southeast
asia
myanmar
preval
adult
male
femal
respect
healthi
children
male
femal
respect
note
male
femal
possess
mutat
mahidol
variant
occur
children
myanmar
dengu
viru
infect
one
lead
caus
morbid
mortal
children
live
tropic
subtrop
region
accord
approxim
million
peopl
worldwid
experi
dengu
infect
annual
southeast
asia
dengu
lead
death
annual
myanmar
four
dengu
serotyp
known
cocircul
children
highest
risk
infect
report
case
fatal
rate
per
dengu
case
dengu
patient
present
undifferenti
febril
ill
may
progress
life
threaten
diseas
patient
genet
background
affect
develop
sever
infect
becom
area
interest
defici
one
report
genet
variant
associ
infect
vitro
studi
report
monocyt
individu
increas
suscept
dengu
viru
serotyp
infect
along
higher
viral
replic
whether
higher
replic
dengu
viru
individu
increas
likelihood
diseas
sever
remain
unknown
herein
investig
associ
defici
sever
dengu
infect
paediatr
patient
myanmar
crosssect
prospect
studi
conduct
yankin
children
hospit
yangon
august
august
paediatr
patient
age
rang
year
fever
day
clinic
suspect
dengu
fever
screen
written
inform
consent
verbal
assent
taken
caregiv
children
respect
three
millilitr
blood
taken
sera
test
antigen
well
igm
igg
antibodi
use
sd
biolin
dengu
duo
rapid
diagnost
test
rdt
standard
diagnost
korea
patient
posit
antigen
andor
dengu
igm
result
enrol
patient
diagnosi
dengu
coinfect
immunocompromis
statu
eg
steroid
use
chemotherapi
andor
posit
hiv
statu
exclud
patient
follow
week
admiss
convalesc
serum
sampl
collect
complet
blood
count
cbc
reticulocyt
count
rc
activ
measur
within
hour
collect
acut
sera
activ
assess
via
spectrophotometri
randox
laboratori
uk
adjust
median
valu
activ
male
cohort
use
defin
variou
cutoff
point
dengu
sever
classifi
accord
classif
guidelin
acut
convalesc
sampl
store
prior
test
activ
cbc
rc
recheck
least
one
month
first
sampl
collect
patient
risk
misdiagnos
defici
base
analys
first
blood
sampl
collect
patient
rc
valu
suffer
recov
acut
haemolyt
anaemia
blood
transfus
first
sampl
collect
studi
protocol
approv
ethic
review
committe
depart
medic
research
myanmar
approv
number
ethic
committe
faculti
tropic
medicin
mahidol
univers
thailand
approv
number
studi
also
regist
follow
intern
clinic
trial
registri
platform
whoictrp
thai
clinic
trial
registri
tctr
websit
number
data
support
find
studi
avail
protocolsio
http
dengu
infect
confirm
quantit
realtim
rtpcr
antigen
igm
igg
elisa
mahidol
oxford
research
unit
thailand
dengu
viru
elisa
cat
standard
diagnost
inc
south
korea
dengu
viru
igm
elisa
cat
standard
diagnost
inc
south
korea
dengu
viru
igg
elisa
cat
standard
diagnost
inc
south
korea
perform
accord
manufactur
instruct
rna
isol
acut
patient
serum
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
germani
rna
extract
perform
accord
manufactur
protocol
rna
store
use
onestep
revers
transcriptas
rt
pcr
perform
detect
dengu
zika
chikungunya
virus
singl
assay
use
zdc
multipl
rtpcr
assay
biorad
usa
assay
perform
accord
manufactur
protocol
addit
rnase
primer
mix
intern
extract
control
rtpcr
assay
posit
control
provid
kit
neg
control
healthi
donor
sera
templat
control
includ
rna
sampl
perform
duplic
posit
pcr
defin
one
duplic
signal
fix
threshold
respect
target
fam
zika
viru
hex
chikungunya
viru
texa
red
dengu
viru
sampl
store
transport
depart
medic
research
dmr
laboratori
yangon
myanmar
process
within
hour
spectrophotometri
conduct
use
humalys
spectrophotomet
medsourc
ozon
biomed
delhi
india
kit
randox
cat
pd
randox
laboratori
ltd
crumlin
uk
procedur
provid
manual
kit
follow
normal
defici
control
cat
pd
defici
cat
pd
normal
randox
laboratori
ltd
crumlin
uk
use
result
consid
valid
measur
activ
control
within
refer
rang
enzym
activ
determin
spectrophotomet
set
measur
rate
absorb
nm
ultraviolet
light
enzym
activ
calcul
adjust
hb
concentr
valu
complet
blood
count
cbc
record
time
sampl
collect
adjust
median
valu
activ
male
cohort
use
defin
variou
cutoff
point
dna
sampl
extract
whole
blood
use
qiaamp
dna
blood
mini
kit
qiagen
germani
accord
manufactur
recommend
three
variant
mahidol
kaip
mediterranean
previous
report
individu
myanmar
detect
realtim
pcr
biorad
cfx
realtim
system
thermal
cycler
biorad
usa
genotyp
pcr
melt
curv
analysi
use
duallabel
selfquench
probe
perform
use
reaction
contain
iq
multiplex
power
mix
forward
revers
primer
snp
wt
probe
steril
distil
water
genom
dna
amplif
condit
minut
iq
multiplex
power
mix
activ
follow
cycl
second
denatur
min
anneal
extens
genotyp
sampl
run
togeth
plasmid
control
target
mutat
three
separ
pcr
reaction
run
everi
sampl
three
differ
mutat
fluoresc
ct
valu
use
cfx
manag
softwar
biorad
usa
use
determin
genotyp
sampl
result
verifi
examin
pcr
curv
gener
elimin
falseposit
result
due
aberr
light
emiss
tabl
laboratori
confirm
acut
dengu
infect
defin
posit
qrtpcr
antigen
ag
elisa
igm
elisa
result
primari
secondari
dengu
infect
defin
accord
neg
posit
igg
elisa
result
febril
phase
day
respect
sever
dengu
infect
classifi
accord
guidelin
dengu
patient
classifi
nonsever
sever
base
clinic
laboratori
paramet
patient
nonsever
dengu
classifi
two
group
base
absenc
presenc
warn
sign
nonsever
dengu
without
warn
sign
defin
patient
fever
follow
criteria
nauseavomit
rash
ach
pain
tourniquet
test
posit
leucopoenia
without
present
warn
sign
warn
sign
includ
abdomin
pain
tender
persist
vomit
clinic
fluid
accumul
mucos
bleed
lethargyrestless
liver
enlarg
increas
haematocrit
concurr
rapid
decreas
platelet
count
per
sever
dengu
defin
dengu
shock
syndrom
dss
fluid
accumul
respiratori
distress
andor
sever
bleed
necessit
blood
transfus
involv
organ
dss
diagnos
presenc
hypotens
narrow
puls
pressur
mmhg
classif
base
activ
express
percentag
median
valu
normal
male
popul
class
iv
defin
class
associ
chronic
nonspherocyt
haemolyt
anaemia
class
ii
class
iii
class
iv
class
v
studi
defici
classifi
sever
moder
normal
enzym
activ
respect
adjust
median
enzym
activ
male
determin
activ
studi
popul
patient
laboratori
confirm
acut
dengu
infect
includ
statist
analysi
data
evalu
use
descript
statist
median
interquartil
rang
continu
variabl
frequenc
percentag
categor
variabl
chisquar
test
fisher
exact
test
categor
variabl
u
test
continu
variabl
use
compar
analys
sever
nonsever
dengu
infect
patient
without
defici
associ
statu
dengu
sever
evalu
use
binari
logist
regress
test
confid
interv
data
analys
use
ibm
spss
statist
ibm
armonk
ny
usa
data
manag
softwar
packag
total
patient
clinic
suspect
dengu
infect
screen
rdt
studi
patient
exclud
nondengu
past
dengu
infect
patient
enrol
studi
defin
posit
ag
andor
igm
result
indic
fig
enrol
patient
exclud
suffici
blood
volum
neg
dengu
result
lack
quantit
result
total
patient
laboratori
confirm
acut
dengu
infect
quantit
result
includ
analysi
fig
among
patient
confirm
acut
dengu
infect
classifi
sever
dengu
classifi
nonsever
dengu
among
patient
nonsever
dengu
present
warn
sign
without
patient
sever
dengu
present
dengu
shock
syndrom
dss
among
dss
patient
one
patient
also
fluid
overload
respiratori
distress
one
patient
sever
bleed
necessit
blood
transfus
ten
fiftyon
children
sever
dengu
admit
icu
requir
blood
transfus
patient
sever
dengu
significantli
younger
p
hospitalis
longer
time
p
compar
nonsever
dengu
patient
major
patient
classifi
secondari
dengu
classifi
primari
dengu
sever
dengu
significantli
higher
secondari
dengu
patient
compar
nonsever
group
p
nausea
vomit
frequent
patient
sever
dengu
p
howev
posit
tourniquet
test
less
frequent
children
sever
dengu
p
clinic
warn
sign
includ
tachycardia
hypotens
significantli
detect
patient
sever
dengu
p
patient
sever
dengu
also
significantli
higher
haematocrit
higher
leukocyt
count
lower
platelet
count
nonsever
dengu
patient
tabl
median
activ
dengueconfirm
patient
ug
hb
adjust
male
median
valu
activ
determin
exclud
male
sampl
activ
deriv
valu
adjust
male
median
ug
hb
tabl
base
valu
activ
ug
hb
defin
class
activ
ug
hb
class
ii
ug
hb
class
iii
ug
hb
class
iv
ug
hb
class
v
popul
tabl
preval
phenotyp
defici
base
cutoff
refer
valu
reveal
includ
male
femal
class
ii
sever
defici
includ
male
femal
class
iii
moder
defici
tabl
realtim
pcr
three
known
singl
nucleotid
polymorph
snp
gene
myanmar
mahidol
kaip
mediterranean
perform
dengueconfirm
sampl
male
femal
among
recognis
snp
male
femal
twentyfour
patient
mahidol
mutat
one
femal
kaip
mutat
mediterranean
genotyp
detect
sampl
male
femal
patient
defici
phenotyp
includ
genotyp
studi
among
mutat
male
femal
mutat
among
sampl
patient
without
phenotyp
defici
sampl
male
femal
mutat
tabl
among
patient
mutat
classifi
class
ii
among
heterozyg
male
one
homozyg
femal
one
male
mahidol
mutat
class
iv
patient
reticulocyt
count
test
activ
femal
genotyp
mutat
vari
degre
defici
phenotyp
classifi
class
ii
class
iv
fig
sever
dengu
associ
defici
phenotyp
genotyp
variant
whether
use
cut
ie
includ
hemizyg
male
homozyg
femal
cut
correspond
class
iii
classif
tabl
sever
dengu
diagnos
children
enzym
activ
children
level
p
addit
studi
particip
snp
detect
snp
sever
dengu
p
herein
investig
associ
dengu
fever
defici
children
myanmar
major
children
studi
secondari
dengu
infect
possibl
due
four
dengu
serotyp
circul
endem
area
lead
subsequ
infect
quarter
children
present
studi
sever
dengu
fever
present
dss
frequenc
secondari
dengu
infect
significantli
higher
sever
dengu
nonsever
dengu
group
consist
metaanalysi
studi
asia
describ
associ
dss
secondari
dengu
infect
associ
sever
dengu
infect
enzym
defici
mutat
detect
result
studi
consist
two
earlier
studi
conduct
thailand
tanphaichitr
colleagu
demonstr
correl
defici
dengu
sever
male
paediatr
patient
age
rang
year
dengu
haemorrhag
fever
age
studi
patient
defici
seridhoranakul
et
al
also
demonstr
signific
relationship
defici
dhf
studi
dhf
patient
patient
control
patient
tanphaichitr
et
al
report
higher
preval
defici
male
dhf
patient
compar
bangkok
suggest
male
may
suffer
dhf
preval
defici
paediatr
patient
dengu
infect
present
studi
lower
preval
defici
children
visit
emerg
depart
yankin
children
hospit
age
month
year
old
screen
dengu
via
rdt
vs
respect
studi
defici
diagnos
enzym
activ
adjust
median
valu
slightli
lower
adjust
median
valu
studi
ug
hb
vs
ug
hb
compar
result
two
studi
conduct
set
children
may
suscept
dengu
infect
compar
children
normal
activ
two
vitro
studi
demonstr
human
monocyt
individu
higher
replic
dengu
viru
serotyp
studi
suggest
likelihood
sever
dengu
like
increas
individu
find
studi
support
hypothesi
howev
viral
load
assess
studi
thu
associ
viral
load
viral
replic
clinic
outcom
beyond
scope
studi
differ
dengu
serotyp
also
affect
clinic
outcom
although
dengu
serotyp
assess
studi
previou
studi
describ
preval
serotyp
among
patient
dhf
myanmar
recent
year
dengu
serotyp
addit
four
serotyp
particip
outbreak
associ
defici
viral
load
differ
dengu
serotyp
warrant
futur
studi
differ
mutat
gene
identifi
variant
differ
impact
enzym
activ
might
result
differ
clinic
manifest
one
studi
report
patient
mediterranean
mutat
show
sever
clinic
cours
bacteri
infect
compar
patient
wild
type
patient
mutat
possess
mahidol
variant
consist
previou
studi
myanmar
genotyp
mutat
detect
male
femal
patient
phenotyp
defici
may
due
limit
number
genotyp
sought
previou
research
region
identifi
uncommon
mutat
instanc
union
coimbra
canton
bancon
et
al
report
molecular
heterogen
among
ethnic
along
thaimyanmar
border
six
patient
male
femal
genotyp
mutat
normal
activ
reticulocyt
count
exclud
fals
neg
phenotyp
due
haemolysi
mahidol
consid
moder
sever
variant
vari
activ
classifi
class
iiiii
almost
male
patient
mahidol
variant
enzym
activ
ie
class
ii
find
consist
result
anoth
studi
thaimyanmar
border
signific
associ
mutat
predominantli
mahidol
variant
dengu
infect
found
whether
genotyp
mahidol
could
affect
dengu
sever
exclud
base
current
studi
thu
effect
gene
mutat
dengu
infect
unknown
complementari
studi
perform
differ
popul
studi
demograph
clinic
haematolog
paramet
patient
sever
nonsever
dengu
compar
found
young
age
risk
factor
significantli
associ
sever
dengu
infect
data
collect
myanmar
also
report
highest
case
fatal
rate
seen
infantil
age
group
clinic
paramet
warn
sign
frequent
sever
dengu
patient
agreement
previou
studi
hepatomegali
risk
factor
dss
sever
dengu
infect
abdomin
pain
prognost
factor
sever
dengu
lethargi
best
clinic
sign
identifi
patient
may
progress
sever
dengu
although
patient
persist
vomit
histori
vomit
frequent
present
sever
dengu
patient
group
studi
report
persist
vomit
one
factor
associ
dss
high
mortal
classif
dengu
high
haematocrit
baselin
concurr
rapidli
decreas
platelet
count
list
warn
sign
studi
patient
sever
dengu
significantli
higher
haematocrit
lower
platelet
count
nonsever
dengu
find
studi
also
reinforc
applic
warn
sign
outlin
guidelin
detect
sever
dengu
infect
children
myanmar
strength
studi
prospect
design
acut
dengu
case
confirm
realtim
pcr
viru
elisa
assay
defici
confirm
gold
standard
quantit
spectrophotometr
assay
although
cutoff
level
activ
repres
children
myanmar
reflect
activ
children
dengu
infect
seen
yankin
children
hospit
limit
studi
exampl
dengu
viral
load
serotyp
analys
therefor
abl
detect
relationship
among
viral
load
serotyp
dengu
sever
defici
addit
mutat
assess
particip
impact
rare
variant
previous
report
myanmar
popul
could
analys
may
impact
statist
analysi
paramet
eg
chest
xray
liver
function
test
ultrasound
chest
abdomen
may
affect
dengu
sever
classif
term
major
organ
involv
evid
plasma
leakag
collect
factor
may
affect
studi
outcom
find
associ
defici
dengu
sever
patient
mahidol
common
variant
myanmar
studi
propos
activ
point
enzym
activ
accord
classif
well
preval
defici
predomin
genet
mutat
among
paediatr
patient
studi
reconfirm
use
dengu
classif
paediatr
dengu
patient
myanmar
research
need
explor
factor
relat
dengu
sever
dengu
viru
viral
load
dengu
viru
den
serotyp
genotyp
